Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03987841 · ClinicalTrials.gov registry record · NA

Intervention Mapping to Adapt a Mindfulness-based Intervention for Adults With Diabetes and Emotional Distress

A NA study of Type 2 Diabetes and Stress, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03987841 is a NA study of Type 2 Diabetes and Stress that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03987841, a NA study of Type 2 Diabetes and Stress, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

We will conduct a single-arm pilot study of an integrated mindfulness-based stress reduction (MBSR)/diabetes self-management education (DSME) intervention in a small group of participants, low-income adults with type 2 diabetes and diabetes distress. We will evaluate the preliminary efficacy, acceptability, and feasibility of the intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Integrated MBSR/DSME intervention

Study Locations (1)

Alabama

  • Cooper Green Mercy Health Systems - Birmingham

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-10-01
Est. Completion 2022-06-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03987841

The ClinicalTrials.gov registry entry for NCT03987841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Integrated MBSR/DSME intervention is the first listed.

NCT03987841 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03987841 about?

NCT03987841 is a clinical study titled "Intervention Mapping to Adapt a Mindfulness-based Intervention for Adults With Diabetes and Emotional Distress". We will conduct a single-arm pilot study of an integrated mindfulness-based stress reduction (MBSR)/diabetes self-management education (DSME) intervention in a small group of participants, low-income adults with type 2 diabetes and diabetes distress. We will evaluate the preliminary efficacy, accept...

What is the current status of trial NCT03987841?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-10-01. Estimated completion is 2022-06-30.

What conditions does trial NCT03987841 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Stress.

What interventions are being tested in trial NCT03987841?

The interventions under investigation include: Integrated MBSR/DSME intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03987841?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03987841 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.